Relmada Therapeutics (RLMD) HAP Data Significantly Improves Commercial Outlook - Analyst

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. INTU
2. DKS
3. META
4. ZM
5. SMTC
6. SPY
7. NCNO
8. NVDA
9. JAZZ
10. BOX

Go back to Relmada Therapeutics (RLMD) HAP Data Significantly Improves Commercial Outlook - Analyst
(NASDAQ: RLMD) Delayed: 4.57 -0.02 (0.44%)
Previous Close $4.59    52 Week High $4.10 
Open $4.57    52 Week Low $0.87 
Day High $4.59    P/E N/A 
Day Low $4.46    EPS $0.00 
Volume 247,887